U.S. Acellular Dermal Matrices Market, By Origin (Human Dermis, Porcine Dermis, Bovine Dermis), By Application (Acute Wounds (Burns, Trauma, Cancers, Infections) Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcer, and Others), and Rec

Acellular dermal matrices are generated by decellularization process, which leads to the removal of the cells and preserving of the extracellular matrix. The extracellular matrix ones implanted in the required area, serves as the scaffold for the donor cells. The donor cells help in the revascularization, which in turn generates a new tissue. The main components of acellular dermal matrix include collagen and elastic fibers. Acellular dermal matrices are mostly used in breast surgery and plastic surgery. Seroma, infection, mastectomy skin necrosis, and expander/implant loss are the most commonly reported complications of acellular dermal matrices with respect to breast surgery.

Market Dynamics

The key player in the market focusing on adopting inorganic growth strategies such as acquisition and collaboration expected to drive the growth of acellular dermal matrices market over the forecast period. For instance, In December 2020, Integra Lifesciences Corporation acquired ACell, Inc., a U.S.-based biotechnology company. The acquisition helped Integra to expand its portfolio of acellular dermal matrix. Furthermore, In December 2019, Smith & Nephew Plc. Acquired Osiris Therapeutics Inc., a regenerative medicine company that offers skin, bone graft, and articular cartilage substitutes. The

acquisition helped Smith & Nephew Plc. To expand its product portfolio of acellular dermal matrix. Moreover, In April 2019, Cook Biotech, a biotechnological subsidiary of Cook Group, entered into a sales collaboration with Progressive Medical Inc., a U.S.-based medical products sales and marketing company. As a result of this sales collaboration, sales representatives employed by Progressive Medical would manage and support sales for the Cook Biotech Biodesign Hernia Graft in the U.S.

Key features of the study:

• This report provides in-depth analysis of the U.S. acellular dermal matrices market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the U.S. acellular dermal matrices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, Marine Polymer Technologies, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• U.S. acellular dermal matrices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing U.S. acellular dermal matrices market

• U.S. Acellular Dermal Matrices Market, By Origin:
• Human Dermis
• Porcine Dermis
• Bovine Dermis
• U.S. Acellular Dermal Matrices Market, By Application:
• Acute Wounds
• Burns
• Trauma
• Cancers
• Infections
• Chronic Wounds
• Diabetic Foot Ulcers
• Venous Leg Ulcers
• Pressure Ulcer
• Others
• Reconstruction Procedures
• Abdominal Wall Procedures
• Breast Procedures
• Orthopedic Procedures
• Others
• U.S. Acellular Dermal Matrices Market, By Place of Setting
• Hospitals
• In- patient
• Out- patient
• Ambulatory Surgical Centers
• Office Based
• Company Profiles
• Integra LifeSciences Corporation
• Abbvie Inc.
• Johnson & Johnson
• HansBioMed
• Becton, Dickinson and Company
• Cook Group
• Smith & Nephew Plc.
• Reprise Biomedical
• Organogenesis Holdings Inc.
• Tissue Regenix
• LifeNet Health
• Zimmer Biomet Holdings, Inc.
• Stryker Corporation
• MiMedx Group
• PolyNovo Limited
• Fidia Pharma USA Inc.
• Baxter International Inc.
• In2Bones Global
• BioHorizons, Inc.
• Harbor MedTech, Inc.
• MLM Biologics Inc.
• Geistlich Pharma AG
• Olaregen Therapeutix, Inc
• EnColl Corporation
• Kerecis limited
• DSM
• ACell Inc.
• 3M
• Cell Constructs I, LLC
• Marine Polymer Technologies, Inc.